Research programme: prodrug therapeutics - V ClinBio/Cellix Bio
Alternative Names: CLX 106Latest Information Update: 28 Mar 2022
At a glance
- Originator Cellix Bio
- Class Acyclic acids; Fatty acids; Omega 3 fatty acids; Small molecules
- Mechanism of Action Immunosuppressants; Inosine monophosphate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Multiple sclerosis